Please try another search
For the nine months ended 30 September 2016, WaferGen Bio-systems, Inc. revenues increased 44% to $6.8M. Net loss increased 7% to $13M. Revenues reflect Product increase of 55% to $6.8M. Higher net loss reflects Sales and marketing increase of 37% to $5.3M (expense), General and administrative increase of 7% to $3.9M (expense), Gain on revaluation of warrant derivativ decrease of 96% to $4K (income).
Period Ending: | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
---|---|---|---|---|
Total Revenue | 2.39 | 2.52 | 1.93 | 2.4 |
Gross Profit | 1.27 | 1.12 | 1.08 | 1.12 |
Operating Income | -3.57 | -4.76 | -4.31 | -3.26 |
Net Income | -3.67 | -4.89 | -4.41 | -3.21 |
Period Ending: | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
---|---|---|---|---|
Total Assets | 11.39 | 15.04 | 18.67 | 22.87 |
Total Liabilities | 7.72 | 7.92 | 7.11 | 7.18 |
Total Equity | 3.67 | 7.11 | 11.55 | 15.7 |
Period Ending: | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -9.61 | -7.5 | -4.15 | -14.64 |
Cash From Investing Activities | -0.3 | -0.26 | -0.16 | -0.31 |
Cash From Financing Activities | -0.18 | -0.13 | -0.04 | 15.45 |
Net Change in Cash | -10.09 | -7.88 | -4.35 | 0.5 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review